GC Wealth Management RIA’s Gilead Sciences GILD Stock Holding History

GC Wealth Management RIA’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$421K	Buy	3,335 +89	+3%	+$11.7K	0.02%	357
2026 Q1	$452K	Sell	3,246 -1,381	-30%	-$193K	0.02%	362
2025 Q4	$568K	Sell	4,627 -16,685	-78%	-$2.03M	0.02%	337
2025 Q3	$2.37M	Buy	21,312 +11,832	+125%	+$1.34M	0.08%	196
2025 Q2	$1.05M	Buy	9,480 +7,332	+341%	+$780K	0.09%	197
2025 Q1	$241K	Sell	2,148 -20	-0.9%	-$2.06K	0.04%	272
2024 Q4	$200K	Sell	2,168 -225	-9%	-$20.3K	0.04%	286
2024 Q3	$201K	Buy	+2,393	New	+$183K	0.04%	289

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

GC Wealth Management RIA's GILD Position: Q2 2026 in Review

GC Wealth Management RIA increased its Gilead Sciences (GILD) stake by 2.7% in Q2 2026, buying an estimated $11.7K and bringing the position to 3,335 shares worth $421K. The position accounts for 0.02% of the portfolio, ranked #357.

GC Wealth Management RIA first reported a position in GILD in Q3 2024 and has held it in 8 quarters since. The position peaked at $2.37M in Q3 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

GC Wealth Management RIA held 3,335 shares of Gilead Sciences worth $421K as of Q2 2026.
GC Wealth Management RIA bought 89 Gilead Sciences shares in Q2 2026, an estimated $11.7K.
Gilead Sciences made up 0.02% of GC Wealth Management RIA's portfolio in Q2 2026, its #357 holding.
GC Wealth Management RIA first reported a position in Gilead Sciences in Q3 2024 and has held it in 8 quarters since.
GC Wealth Management RIA's Gilead Sciences position peaked at $2.37M in Q3 2025.
2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on GC Wealth Management RIA's 13F filing for Q2 2026, filed 16 Jul 2026.